Generics attack validity of Neurim insomnia drug patent

Intellectual Property 2019-04-05 8:28 pm By Miklos Bolza | Sydney

Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should be revoked.